Xiong, Zhongyan
Geng, Zhijun
Lian, Shanshan
Yin, Shaohan
Xu, Guixiao
Zhang, Yunfei
Dai, Yongming
Zhao, Jing
Ma, Lidi
Liu, Xin
Zheng, Hairong
Zou, Chao
Xie, Chuanmiao
Funding for this research was provided by:
National Natural Science Foundation of China (61901462, 81801724)
Guangdong Grant Key Technologies for Treatment of Brain Disorders’ (2018B030332001)
Scientific Instrument Innovation Team of the Chinese Academy of Sciences (GJJSTD20180002)
International Partnership Program of Chinese Academy of Sciences Grant (154144KYSB20180063)
Strategic Priority Research Program of Chinese Academy of Sciences (XDB25000000)
Article History
Received: 19 January 2022
Revised: 14 March 2022
Accepted: 15 March 2022
First Online: 4 April 2022
Declarations
:
: All the authors declare that they have no conflict of interest.
: This retrospective study involving human participants were in accordance with the ethical standards of the Institutional Research Committee and with the 1964 Helsinki Declaration and its later amendments. The Human Investigation Committee (IRB) of Sun Yat-sen University Cancer Center approved this study.
: Informed consent was obtained from all individual participants included in the study.